Replies to post #117932 on Biotech Values

[DewDiligence]

“Amgen’s acquisition of Bergamo affectively makes it a generic drugs manufacturer in this massive low-cost drug market.”

Demonstrating once again the blogosphere dilemma that anyone can hit the Send button and then it’s out there.